| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 46.96B | 44.29B | 43.57B | 40.41B | 35.60B | 17.40B |
| Gross Profit | 16.49B | 15.71B | 15.21B | 13.77B | 9.78B | 4.62B |
| EBITDA | 4.87B | 4.84B | 9.51B | 4.55B | 4.66B | 2.20B |
| Net Income | 1.91B | 1.95B | 6.75B | 1.94B | 2.05B | 492.50M |
Balance Sheet | ||||||
| Total Assets | 34.20B | 33.99B | 33.04B | 27.81B | 27.02B | 23.77B |
| Cash, Cash Equivalents and Short-Term Investments | 124.38M | 100.95M | 422.35M | 435.66M | 232.09M | 531.96M |
| Total Debt | 9.03B | 8.28B | 10.48B | 6.38B | 7.78B | 9.37B |
| Total Liabilities | 17.09B | 17.73B | 18.61B | 16.47B | 17.50B | 16.27B |
| Stockholders Equity | 17.11B | 16.26B | 14.42B | 11.35B | 9.52B | 7.49B |
Cash Flow | ||||||
| Free Cash Flow | -182.32M | 3.04B | -1.90B | 2.11B | 2.37B | 1.13B |
| Operating Cash Flow | 992.17M | 5.17B | 1.93B | 3.48B | 4.06B | 1.69B |
| Investing Cash Flow | -1.12B | -1.96B | -3.65B | -1.28B | -1.54B | -370.53M |
| Financing Cash Flow | 152.96M | -3.54B | 1.71B | -2.34B | -2.48B | -1.71B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ₹26.18B | 8.35 | ― | 1.65% | 21.44% | -46.24% | |
76 Outperform | ₹28.48B | 13.58 | ― | 1.36% | -0.46% | 4.85% | |
75 Outperform | ₹22.37B | 20.43 | ― | 1.03% | -1.47% | -15.20% | |
68 Neutral | ₹67.22B | 15.33 | ― | 1.05% | -6.18% | -23.70% | |
65 Neutral | ₹29.20B | 16.33 | ― | 0.65% | 9.22% | -71.14% | |
62 Neutral | ₹39.34B | 20.39 | ― | 0.28% | 6.44% | 36.54% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |